Updates on $ACOG.V good to see $ACOG.V in the green today, its been a while since we've received new updates from Alpha. neurodegenerative diseases are a continuing core area for new studies and trials to find better treatments and eventually, a cure. both treatments and a cure are the need of the hour and once established will stay for the long run which is why I have so much faith in $ACOG.V, their treatments are long-term performers and I really think the price will show a sharp incline the moment we receive new updates from the company.
td, $ACOG.V trading at $1.16 with market cap at $71.34 M